Immobilized ACE-2 Fc Chimera, Human (Cat. No. Z03484) at 2 μg/mL can bind SARS-CoV-2 Spike protein (S1, del 69-70, N439K, His Tag) ( Cat. No. Z03524) with a serial dilution.
THETM His Tag Antibody [HRP], mAb, Mouse (Cat.No.A00612) is used as a secondary antibody (0.2 μg/mL).
Lane 1: 1μg of SARS-CoV-2 Spike protein (S1, del 69-70, N439K, His Tag), reducing(R)
> 90% as analyzed by SDS-PAGE
Species | SARS-CoV-2 | ||||
Protein Construction |
|
||||
Purity | > 90% as analyzed by SDS-PAGE | ||||
Endotoxin Level | < 0.2 EU/μg of protein by gel clotting method | ||||
Biological Activity | SARS-CoV-2 Spike protein (S1, del 69-70, N439K, His Tag) can bind with human ACE2 (Cat. No.: Z03484) in functional ELISA assay. | ||||
Expression System | 293 Cells | ||||
Theoretical Molecular Weight | 79 kDa | ||||
Formulation | Supplied as a solution in PBS pH 7.4 | ||||
Concentration | Please refer to the COA for the specific lot. | ||||
Storage & Stability | Upon receiving, this product remains stable for up to 6 months at -20°C or below. Avoid repeated freeze-thaw cycles. |
Immobilized ACE-2 Fc Chimera, Human (Cat. No. Z03484) at 2 μg/mL can bind SARS-CoV-2 Spike protein (S1, del 69-70, N439K, His Tag) ( Cat. No. Z03524) with a serial dilution.
THETM His Tag Antibody [HRP], mAb, Mouse (Cat.No.A00612) is used as a secondary antibody (0.2 μg/mL).
Lane 1: 1μg of SARS-CoV-2 Spike protein (S1, del 69-70, N439K, His Tag), reducing(R)
> 90% as analyzed by SDS-PAGE
Target Background | SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) also known as 2019-nCoV (2019 Novel Coronavirus) is a virus that causes illnesses ranging from the common cold to severe diseases. SARS-CoV-2 Spike Protein is composed of S1 domain and S2 domain. The spike protein mutation del 69-70 and N439K may help the virus escape the host's immune response. |
Synonyms | SARS-CoV-2 S1 protein, del 69-70, N439K; 2019-nCoV S1 protein, del 69-70, N439K |
For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.
For more documents, please visit "Technical Support".